MICRON TECHNOLOGY, INC. (NASDAQ: MU) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Micron Technology, Inc. Investors of Upcoming Deadline

(NASDAQ:MU), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Do you, or did you, own shares of Micron Technology, Inc. (NASDAQ: MU)? Did you purchase your shares between September 28, 2023 and December 18, 2024, inclusive? Did you lose money in your investment in Micron Technology, Inc.? Do you want to discuss your rights? Bernstein […]

KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kyverna Therapeutics, Inc. Investors of Upcoming Deadline

(NASDAQ:KYTX), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP: Do you, or did you, own shares of Kyverna Therapeutics, Inc. (NASDAQ: KYTX)? Did you purchase your shares pursuant and/or traceable to Kyverna's February 8, 2024's initial public offering? Did you lose money in your investment in Kyverna Therapeutics, Inc.? Do you want

CUSTOMERS BANCORP, INC. (NYSE: CUBI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Customers Bancorp, Inc. Investors of Upcoming Deadline

(NYSE:CUBI), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP: Do you, or did you, own shares of Customers Bancorp, Inc. (NYSE: CUBI)? Did you purchase your shares between March 1, 2024 and August 8, 2024, inclusive? Did you lose money in your investment in Customers Bancorp, Inc.? Do you want to discuss

WARNER BROS. DISCOVERY, INC. (NASDAQ: WBD) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Warner Bros. Discovery, Inc. Investors of Upcoming Deadline

(NASDAQ:WBD), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP: Do you, or did you, own shares of Warner Bros. Discovery, Inc. (NASDAQ: WBD)? Did you purchase your shares between February 23, 2024 and August 7, 2024, inclusive? Did you lose money in your investment in Warner Bros. Discovery, Inc.? Do you want

PayBright Adds Industry Leader Thad Sheffield to its Leadership Team

RALEIGH, N.C., Jan. 21, 2025 (GLOBE NEWSWIRE) — PayBright, a leading merchant services provider, announced today the company has added payments industry leader Thad Sheffield as its first Director of Agent Success and Experience. Tasked with driving corporate growth and expansion while continuing to deliver exceptional client experiences, Sheffield brings more than 25 years of

CovarsaDx® Research Team Provides Key Support for the FDA 510(k) Clearance for OSANG Healthcare’s Over-The-Counter QuickFinder™ COVID-19/Flu Antigen Self-Test and QuickFinder™ COVID-19/Flu Antigen Pro Test

CovarsaDx®, a prominent Clinical Research Organization (CRO) renowned for its expertise in the areas of in-vitro diagnostics (IVDs) and medical devices,proudly announced today that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the QuickFinder™ COVID-19/Flu Antigen Self-Test (Self Test) and QuickFinder™ COVID-19/Flu Antigen Pro Test (Pro Test). CovarsaDx, on behalf of test

VaynerX and Ipsos Study Unveils 5 Key Insights on the Value of Organic Social Media for Marketers

Today, modern-day communications company VaynerX and Ipsos, one of the world's leading market research companies, unveil key insights underscoring the importance of Organic Social and its untapped potential for marketers. “Organic Social Media is no longer a supporting act or after thought in marketing. Its potential to transform consumer engagement, build brand awareness and equity

Scroll to Top